Zhejiang NHU Company Ltd.
002001
株式のランク
#1823
Zhejiang NHU Company Ltd., founded in 1999 and headquartered in Xinchang,... Zhejiang NHU Company Ltd., founded in 1999 and headquartered in Xinchang, China, specializes in the nationwide production and distribution of a broad spectrum of chemical products. Its principal operations are divided into four main categories: 1. Nutritional Products: The company offers a comprehensive range of supplements, including essential vitamins (E, A, C, D3, biotin), DL-Methionine, coenzyme Q10, and various carotenoids. These ingredients are critical for enhancing animal feed and fortifying food, beverages, and health-related products. 2. Flavors and Fragrances: This segment supplies a variety of aroma chemicals, such as derivatives from the linalool and citral series, cis-3-hexenol, methyl dihydrojasmonate, raspberry ketone, and ligustral, which are widely utilized in personal care items, cosmetic formulations, and food flavorings. 3. New Polymer Materials: Zhejiang NHU provides advanced polymer solutions like polyphenylene sulfide and polyphthalamide. These materials find essential applications across industries including electronics, automotive manufacturing, and environmental protection. 4. Active Pharmaceutical Ingredients (APIs): The company manufactures crucial pharmaceutical components, including moxifloxacin hydrochloride, vitamin A, and vitamin D3, which serve as foundational substances for the development and production of various drug preparations.
株価
$3.81
最終同期: 2026-10-20
時価総額
$11.71B
変化（1日）
0.42%
変化（1年）
16.65%
国
CN
取引 Zhejiang NHU Company Ltd. (002001)
カテゴリー
Healthcare
Zhejiang NHU Company Ltd.（002001）の利益
Jun 2026 時点の利益 TTM: $1.21B
Zhejiang NHU Company Ltd. の最新の財務報告によると、同社の現在の利益は $1.21B です。2023 年には $459.63M の利益を上げ、これは 2022 年の利益 $614.40M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Zhejiang NHU Company Ltd. の利益の推移（2001 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $1.21B | 26.70% |
| 2024 | $951.29M | 106.97% |
| 2023 | $459.63M | -25.19% |
| 2022 | $614.40M | -22.87% |
| 2021 | $796.54M | 26.61% |
| 2020 | $629.13M | 70.77% |
| 2019 | $368.41M | -30.38% |
| 2018 | $529.13M | 62.53% |
| 2017 | $325.55M | 50.68% |
| 2016 | $216.05M | 191.57% |
| 2015 | $74.10M | -54.85% |
| 2014 | $164.11M | -6.01% |
| 2013 | $174.61M | 6.83% |
| 2012 | $163.44M | -23.81% |
| 2011 | $214.53M | 6.79% |
| 2010 | $200.88M | 12.80% |
| 2009 | $178.08M | -26.08% |
| 2008 | $240.92M | 1,476.45% |
| 2007 | $15.28M | 154.47% |
| 2006 | $6.01M | -45.54% |
| 2005 | $11.03M | -14.93% |
| 2004 | $12.96M | -2.47% |
| 2003 | $13.29M | 29.54% |
| 2002 | $10.26M | 61.50% |
| 2001 | $6.35M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 46.40% |
IN
|
